Overall, disconcordance was mainly due to downregulation of FRα in biopsy- and metastastic tissue compared to primary NSCLC and breast cancer, which could be a result of tissue sampling or of heterogeneity of FRα expression. Here, FOLR1 is linked to non-small cell lung carcinoma.